Astrana Health reported a strong first quarter with a 20% increase in revenue, a 13% increase in net income attributable to Astrana, and a 42% increase in adjusted EBITDA compared to the prior year quarter. This performance was primarily driven by solid membership growth across all lines of business and successful management of total cost of care for members. The total number of lives managed increased to approximately one million due to 10% organic membership growth year-to-date.
Revenue grew by 20% year-over-year.
Net income attributable to Astrana increased by 13% year-over-year.
Adjusted EBITDA grew by 42% year-over-year.
Organic membership growth of 10% year-to-date increased total lives managed to approximately one million.
Astrana is reiterating its guidance for total revenue, net income attributable to Astrana, Adjusted EBITDA, and EPS - diluted for the year ending December 31, 2024, based on the Company’s existing business, current view of existing market conditions and assumptions.
Analyze how earnings announcements historically affect stock price performance